Boston Harbor Angels, like a lighthouse, helps entrepreneurs navigate and grow their start-up businesses through the treacherous waters of an increasingly competitive environment in our global economy.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of our assets in high-growth, early-stage companies. Since 2004 we have made investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc. We believe we contribute more than money to the companies we fund and welcome the opportunity to work with entrepreneurs who are open to taking advice, yet have the smarts and determination to make their company successful.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of our assets in high-growth, early-stage companies. Since 2004 we have made investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc. We believe we contribute more than money to the companies we fund and welcome the opportunity to work with entrepreneurs who are open to taking advice, yet have the smarts and determination to make their company successful.
Employees: 1-10
Founded date: 2005
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 17.02.2026 | GelMEDIX, ... | gelmedix.com | $13M | United Sta... |
Mentions in press and media 12
| Date | Title | Description |
| 23.02.2026 | GelMEDIX Secures $13 Million to Advance Vision Restoration | GelMEDIX, a biotechnology innovator, closed a $13 million seed funding round. Safar Partners spearheaded the investment. This capital fuels the company's lead program, GMX-101. GMX-101 targets late-stage Geographic Atrophy, a devastating fo... |
| 17.02.2026 | GelMEDIX Raises $13M in Seed Funding | GelMEDIX, a Cambridge, MA-based biotechnology company developing regenerative therapies to restore vision, raised $13M in Seed funding. The round was led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Bosto... |
| 17.02.2026 | GelMEDIX: $13 Million Seed Funding Closed For Vision Restoration Biotechnology Platform | GelMEDIX, a biotechnology company developing regenerative therapies to restore vision, has completed a $13 million seed financing round led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Boston Angels, Bost... |
| 05.03.2019 | Emovi raises $15 million CAD Series C led by TVM Capital Life Science | Montreal-based Emovi has announced a $15 million CAD Series C with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital. This investment brings Emovi’s total funds raised to $20 million. “These investments enabl... |
| 26.06.2014 | Device startup raises $2M to build iPod-sized wearable that uses ultrasound for pain | Update In an emailed statement from co-founder and CSO George Lewis, he said: “It is so gratifying that the investor community has acknowledged the rapid growth of the wearable, medical technology industry and has made a significant investm... |
| 18.12.2012 | Golden Seeds joins $6.4M financing round for therapeutic combating ulcerative colitis | Cherrystone Angel Group, an existing investor, co-led the round with Golden Seeds. Other investors participating in the round were Beacon Angels, Boston Harbor Angels, Launchpad Venture Group, Mass Medical Angels, and North Country Angels; ... |
| 27.08.2012 | Attention life science startups: Super angel consortium seeks to fill investment void | “Venture capital firms have invested in life science companies, but collectively the returns have been poor, and the risk profile has gone up because of the sluggish performance by the FDA,” Rudnick told MedCity News. “What has happened is ... |
| 10.11.2011 | Avaxia Biologics Raises $2.2M in Series A Financing | Avaxia Biologics, Inc., a Lexington, MA-based biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, completed a $2.2m first close of a Series A financing. The round was led by Cherrystone Angels,... |
| 07.10.2008 | CollegeWikis bags $2M to make old-fashioned email groups a thing of the past | Every college student’s inbox has at one time been flooded with group emails from classes, dorms, clubs and more. Student-founded startup CollegeWikis, which just received $2 million in funding, hopes to retire this system, and make more in... |
| - | Golden Seeds joins $6.4M financing round for therapeutic combating ulcerative colitis | A pharmaceutical startup gearing up for clinical trials for its antibody targeting digestive maladies has raised $6.4 million in a Series B financing round. Golden Seeds, an angel investment group that typically allocates funds to life scie... |
Show more